Cyclerion Therapeutics, Inc.
+95.3% · 90d
$2.93
-0.01 (-0.34%)
After-Hours $2.90(-0.03)
News
(1)April 2026
Cyclerion Therapeutics, Inc. — 8-K Filing
CYCNCyclerion Therapeutics, Inc.
# 🧾 What This Document Is This is an 8-K filing from Cyclerion Therapeutics (CYCN). It contains the signed legal agreements for a major corporate transaction announced on April 1, 2026. Think of this as the "fine print" and commitments that make the headline deal official. There are three key exhi
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%